Direct oral anticoagulants versus warfarin for venous thromboembolism prophylaxis in nephrotic syndrome patients: a retrospective study
Abstract Background Nephrotic syndrome (NS) is associated with an increased risk of venous thromboembolism (VTE). Anticoagulants are widely used in the prevention of VTE in NS patients. The use of direct oral anticoagulants (DOACs) has not been studied intensively in NS patients. The aim of this stu...
Saved in:
Main Authors: | Ahmed El-Bardissy, Mohamed Nabil Elshafei, Hebatullah Abdelgawad, Rana Mekkawi, Asma Eltahir, AbdulMoqeeth Mohammed, Ashour AM, Hazem Elewa |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Thrombosis Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12959-025-00685-0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Factors related to the choice of warfarin for treating newly diagnosed nonvalvular atrial fibrillation are associated with safety outcomes during anticoagulation: A new‐user, active‐comparator, retrospective cohort study
by: Yoshiko Takagi, et al.
Published: (2024-12-01) -
Risk of mortality between warfarin and direct oral anticoagulants: population-based cohort studies
by: Zixuan Wang, et al.
Published: (2024-12-01) -
Direct oral anticoagulants (DOACs) for postoperative venous thromboembolism prophylaxis in patients with gynecologic malignancies: A quality mini-review
by: Peter W. Ketch, et al.
Published: (2024-12-01) -
Pattern of venous thromboembolism in childhood idiopathic nephrotic syndrome
by: Moustafa Mahmoud Mohamed Marei, et al.
Published: (2024-12-01) -
ADVANTAGES AND DISADVANTAGES OF WARFARIN AND PRADAXA THERAPY FOR VENOUS THROMBOEMBOLISM
by: B. S. Sukovatykh, et al.
Published: (2018-01-01)